Johnson & Johnson Announces Pivotal Clinical Study Results for a New Soft-Tissue Surgical Robotic System
Go back to Johnson & Johnson Announces Pivotal Clinical Study Results for a New Soft-Tissue Surgical Robotic System| Johnson & Johnson (NYSE: JNJ) | Delayed: 231.16 +2.77 (1.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $228.39 | 52 Week High | $126.07 | |||
| Open | $228.95 | 52 Week Low | $94.28 | |||
| Day High | $231.45 | P/E | 48.06 | |||
| Day Low | $227.50 | EPS | $4.81 | |||
| Volume | 2,145,782 | |||||
